News & Analysis on Clinical Trial Services & Contract Research And Development
Over recent years, the Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies. In this article, which originally appeared in the February 2021 publication of “International Clinical Trials,” learn how partnering with a clinical supply provider who has local APAC expertise can be invaluable in order to ensure the reliable supply of clinical materials to patients across the region.
Paid for and content provided by Catalent
The nature and scope of clinical research has changed significantly over the past decade. Studies are more complex, globalized and patient-centric than ever. Yet, the processes used to package and ship study drugs to trial sites are stuck in an earlier...
With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader area landscape in order to develop a distribution strategy that avoids delays and minimizes cost and...
The pharmaceutical industry had to adapt quickly to the pandemic if it was to continue to supply important medicines, while also racing to develop vaccines and treatments.
For more product information visit Catalent.